Home Celularity

Celularity

acquired
IPO
Cellular Medicine Biotechnology R&D Developer

Basic Information

Celularity's innovative approach to cell therapy leverages the unique therapeutic potential locked within postpartum placental cells. We have multiple cell therapy candidates in preclinical and clinical development, as well as placenta-derived products for surgical use.
Celularity, Inc.
NewJersey,United States of America
101~500 people
January 01, 2016
Contact Email media@celularity.com